Browsing Category
Pharma Industry News
4753 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Bio-Path Holdings unveils preclinical success for BP1001-A in treating obesity and Type 2 diabetes
Bio-Path Holdings, Inc. (NASDAQ: BPTH), a biotechnology innovator known for leveraging its DNAbilize liposomal delivery platform, has announced…
Cognition Therapeutics reports promising Phase 2 results for CT1812 in dementia with Lewy bodies
Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage pharmaceutical company focused on neurodegenerative disorder treatment, has reported highly encouraging…
Polyrizon prepares for allergy blocker trial with strategic manufacturing partnership
Polyrizon Ltd., a biotech company known for its cutting-edge nasal hydrogel technology, has solidified its preparations for the…
Corvus Pharmaceuticals shares surge ahead of Phase 1 data release for Soquelitinib
Corvus Pharmaceuticals, a clinical-stage biopharmaceutical company, is poised to announce interim results from its Phase 1 trial evaluating…
Tenaya Therapeutics’ TN-201 demonstrates tolerability and protein expression in early HCM trial
Tenaya Therapeutics, a clinical-stage biotechnology company, has released promising interim results from its MyPEAK-1 Phase 1b/2 clinical trial…
Portage Biotech and Immunova sign LOI for potential iOx Therapeutics acquisition
Portage Biotech, Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing innovative therapies to target cancer, has entered into…
FDA acceptance propels Tonix Pharmaceuticals’ TNX-102 SL towards fibromyalgia treatment approval
Tonix Pharmaceuticals Holding Corp. has achieved a pivotal milestone with the FDA acceptance announcement for its New Drug…
Supriya Lifescience boosts API capacity with Rs 125cr Module E facility
Supriya Lifescience Ltd, a leading player in the pharmaceutical industry growth segment, has unveiled its latest Module E…
Three biosimilars by Celltrion near EU approval following CHMP endorsement
Celltrion, a leading South Korean biopharmaceutical company, has received positive opinions from the European Medicines Agency’s (EMA) Committee…
Gilead Sciences’ seladelpar gains support as PBC treatment in Europe
In a significant milestone for liver disease therapeutics, Gilead Sciences, Inc. has announced that the Committee for Medicinal…